Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $201.20B | $214.55B | $237.13B | $281.00B | $205.86B | $140.69B | $200.32B | $209.36B | $149.10B | $127.92B | $143.42B |
| Research & development | $810.0M | $805.0M | $774.0M | $762.0M | $824.0M | $895.0M | $968.0M | $986.0M | $912.0M | $1.05B | $980.0M |
| Operating expenses | $148.07B | $158.52B | $174.03B | $200.54B | $146.26B | $103.75B | $144.26B | $154.10B | $125.24B | $108.94B | $123.01B |
| Operating income | — | — | — | $50.55B | $24.82B | −$6.32B | $16.26B | $16.02B | $7.75B | $5.46B | $2.69B |
| Net income | $13.13B | $15.76B | $21.38B | $20.53B | $16.03B | −$7.24B | $11.27B | $11.45B | $8.63B | $6.20B | $5.09B |
| Basic EPSper diluted share | $5.84 | $6.74 | $8.72 | $7.91 | $5.95 | -$2.90 | $4.20 | $4.27 | $3.36 | $2.52 | $2.17 |
| Diluted EPSper diluted share | $5.78 | $6.69 | $8.67 | $7.85 | $5.92 | -$2.90 | $4.17 | $4.24 | $3.34 | $2.51 | $2.16 |